Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omeros Corporation (OMER) Institutional Ownership & Insider Trading

172 institutions reported holding Omeros Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 14 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMEROmeros CorporationFollow OMER — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

172 institutions held 49.9% of the shares. Across filers that reported both quarters, shares held changed +17.0%.

Increased+66New+28Decreased-34Closed-22

Largest moves, shares (millions)

UBS Group AG+0.8MBlackRock+0.7MRock Springs Capital…+0.7MPolar Asset Management…-0.2MJump Financial-0.2MDimensional Fund Advisors-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.2Sep 24+1.3Dec 24+0.9Mar 25+1.5Jun 25+3.7Sep 25-1.0Dec 25-2.2Mar 26+5.2Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2617236+17.0%66283422
Mar 2616031-7.6%55304019
Dec 2514933-3.0%57293111
Sep 2512833+12.5%5511318
Jun 2512529+5.4%38123423
Mar 2513528+3.2%29194511
Dec 2412627+5.2%4421259
Sep 2410725-0.7%2010308

Omeros Corporation — questions

Who owns Omeros Corporation stock?
172 institutions reported Omeros Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.3%), INGALLS & SNYDER LLC (5.1%), UBS Group AG (4.3%).
Are Omeros Corporation insiders buying or selling?
14 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Omeros Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.